^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MOG autologous T-lymphocyte cell therapy

    i
    Other names: MOG autologous T-lymphocyte cell therapy, Myelin oligodendrocyte glycoprotein transduced autologous T-lymphocyte cell therapy, MOG cytolytic CD4+ T-cell therapy, MOG peptide gene therapy
    Associations
    News
    Trials
    Company:
    Imcyse
    Drug class:
    T-lymphocyte cell therapy, Myelin protein stimulant
    Related drugs:
    Associations
    News
    Trials